Drugs / Slo-Niacin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00194402 Comparator | Aug 2003 → Jan 2006 | hyperlipidemia | University of Washington | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Slo-Niacin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00194402 ↗ |
| Known as | Slo-Niacin (R) (time-release niacin | “Slo-Niacin (R) (time-release niacin” NCT00194402 ↗ |